Drug shortages continue to be a significant issue in the healthcare system, affecting various aspects of patient care and imposing substantial costs on hospitals and health systems. According to Vizient's 2024 drug shortages survey, U.S. hospitals are spending approximately 20 million hours annually managing these shortages, resulting in nearly $900 million in associated labor costs. The survey highlights that 74% of facilities reported exceeding their pharmacy budgets due to drug shortages, with pediatric facilities facing particularly significant financial and labor strain.

Kyle Hoelting, director of pharmacy supply assurance and stewardship and Nikola Markoski, director of pharmacy sourcing strategic solutions and analytics join host Katie Korte, vice president Vizient Reserve to delve into the results of Vizient’s 2024 drug shortage survey.

Guest speakers:

Kyle Hoelting, Pharm.D, BCPS

Director, Pharmacy Supply Assurance & Stewardship

Vizient Center for Pharmacy Practice Excellence

Nikola Markoski, Pharm.D, MBA

Director, Pharmacy Sourcing Strategic Solutions & Analytics

Vizient

Host:

Katie Kortie, Pharm.D, MHA, BCPS, BCCCP

Vice President, Strategy & Program Lead, Vizient Reserve

Vizient

Show Notes:

[00:47-01:14] Kyle and Niko Backgrounds

[01:15-05:04] What's different about this year's survey and what made 2023 a critical year in the drug shortage landscape

[05:05-08:27] How data was collected, what did the mix of information tells us and the biggest insights or patterns that surfaced in the survey

[08:28-12:25] What Vizient’s built or enabled that’s made a difference in this space

[12:26-15:55] How best to prepare for and respond to shortages from an inventory perspective

Links | Resources:

• Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions
• Drug shortage stewardship: A novel solution for an old problem
• Vizient Key performance indicators for the management of drug shortages
• Vizient Essential Medications List

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

We all know that clinician burnout negatively impacts the quality of patient care. That's why pharmacy residency accrediting bodies now emphasize resident well-being and professional sustainability as core components of residency training earlier in clinician careers. The American Society of Health-System Pharmacists (ASHP) Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies include a formal requirement for programs to address resilience, well-being, and burnout prevention, reflecting the increasing recognition of burnout in healthcare. Joining us to talk that out are Tony Huke, Senior Pharmacy Executive Director with Vizient Pharmacy Advisory Solutions and Kendra Gage, Inpatient Clinical Pharmacist and the PGY 1 Residency Program Director at UCHealth, University of Colorado Hospital in Aurora, Colorado.

Guest speakers:

Tony Huke, PharmD, BCPS, FASHP

Senior Pharmacy Executive Director

Vizient Pharmacy Advisory Solutions

Kendra Gage, PharmD, BCPS

Inpatient Clinical Pharmacist

PGY1 Pharmacy Residency Program Director

UCHealth

Host:

Kerry Schwarz, PharmD, MPH

Senior Clinical Manager, Evidence-Based Medicine and Outcomes

Center for Pharmacy Practice Excellence (CPPE)

Show Notes:

[01:11-03:25] What’s new at the national level in terms of pharmacy resident resiliency and well-being

[03:26-03:56] The intentionality of well-being in pharmacy residency programs

[03:57-05:12] Examples from Kendra’s program

[05:13-06:40] Program expectations to address resilience

[06:41-08:33] Assessment and potential metrics of resiliency programs

[08:34-11:06] The role of pharmacy leadership and residency program directors in resiliency

[11:07-12:34] Impact of resiliency programs so far

Links | Resources:

Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season. Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient.

Guest speakers:

John Schoen, PharmD, BCPS

Senior Clinical Manager of Drug Information

Vizient Center for Pharmacy Practice Excellence

Host:

Stacy Lauderdale, PharmD, BCPS

Associate Vice President

Vizient Center for Pharmacy Practice Excellence

Show Notes:

[01:38-05:32] What changed in the recent CDC update for healthy children

[05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children

[09:33-11:47] Specific risk factors for pediatric patients

[11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women?

[12:48-14:03] The FDA’s proposed regulatory framework for COVID-19 vaccine approval

[14:04-15:18] FDA’s approach to implementing revised requirements for randomized controlled trials

[15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee

[17:00-18:27] Topics requiring further clarification about COVID-19 vaccine

Links | Resources:

Vizient resources:

• Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668
• Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336

Additional resources:

• FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929
• ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html
• CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
• CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
• CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/
• WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths
• MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months: https://www.cdc.gov/mmwr/volumes/73/wr/mm7338a1.htm?utm_source=chatgpt.com
• MMWR – MIS-C, US 2023: https://www.cdc.gov/mmwr/volumes/73/wr/mm7310a2.htm

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed